Mesenchymal Stem Cells for the Treatment of Perianal Fistulizing Crohn's Disease
Status:
Recruiting
Trial end date:
2022-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and efficacy of using adult allogeneic
bone marrow derived mesenchymal stem cells (MSCs), to treat people for medically refractory
perianal fistulizing Crohn's disease.